Matt Silver

Matt Silver is an experienced professional in oncology precision medicine, currently serving as VP and Head of Oncology Precision and Translational Medicine at Takeda since June 2021. Previously, Matt held various leadership roles at Takeda, including Interim Head of Oncology Precision and Translational Medicine and Senior Director of Oncology Companion Diagnostics. Prior to joining Takeda, Matt worked at EMD Serono, Inc. as Director of Companion Diagnostics and Principal Scientist focusing on clinical biomarkers and immuno-oncology. Earlier experience includes positions at Cell Signaling Technology and Wyeth, where Matt contributed to clinical assay development and research. Matt holds a PhD in Biochemistry from the University of New Hampshire and a BS in Molecular and Cell Biology from the University of Connecticut.